Pharvaris N.V. (PHVS)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20263 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Pharvaris N.V.’s names, not what it holds today.
0 published
3 published
Names not counted (2)
| Granted | Patent | Title | Field | Owner as printed |
|---|---|---|---|---|
| Nov 21, 2023 | 11,820,756 | Bradykinin B2 receptor antagonists | Organic fine chemistry | PHARVARIS NETHERLANDS B.V. |
| Mar 1, 2022 | 11,261,173 | Bradykinin B2 receptor antagonists | Organic fine chemistry | PHARVARIS NETHERLANDS B.V. |
| Nov 17, 2020 | 10,836,748 | Bradykinin B2 receptor antagonists | Organic fine chemistry | PHARVARIS NETHERLANDS B.V. |
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| May 5, 2022 | 2022/0135543 | NOVEL BRADYKININ B2 RECEPTOR ANTAGONISTS | Organic fine chemistry | Pharvaris Netherlands B.V. · patent 11,820,756 granted from it |
| Jan 21, 2021 | 2021/0017158 | NOVEL BRADYKININ B2 RECEPTOR ANTAGONISTS | Organic fine chemistry | Pharvaris Netherlands B.V. · patent 11,261,173 granted from it |
| Aug 13, 2020 | 2020/0255405 | NOVEL BRADYKININ B2 RECEPTOR ANTAGONISTS | Organic fine chemistry | Pharvaris Netherlands B.V. · patent 10,836,748 granted from it |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.